DAWN vs EW · rev $131.2M vs P/E 47, rev $1.39B
Day One Biopharmaceuticals Inc (DAWN) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
Day One Biopharmaceuticals Inc (DAWN) is a biotechnology company listed on US.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported DAWN revenue for 2024-12-31 was $131.2M. Net income was -$95.5M. DAWN currently screens at market cap $656.8M.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
DAWN currently screens at market cap $656.8M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the DAWN and EW stock pages for the full models.
Not investment advice.